Synthesis and assessment of the cytotoxic effect of some of 1,4-dihydropyridine derivatives which contain azole moiety Scientific paper
Main Article Content
Abstract
A number of 1,4-dihydropyridine derivatives (9a–d, 10a–d and 11a–d) were designed and synthesized by the reaction of 1,3,4-oxadiazole-5-thiones and 1,2,4-triazole-5-thiones to 2,6-dibromomethyl-3,5-diethoxycarbonyl-4-(3-nitrophenyl)-1,4-dihydropyridine. The synthesized compounds were characterized using FT-IR, 1H-NMR, 13C-NMR spectral data, ESI-MS and elemental analysis. The cytotoxicity of the synthesized compounds was evaluated in human breast cancer (MCF-7) cells based on the results of MTT assay. The results indicated that compound diethyl 4-(3-nitrophenyl)-2,6-bis[((5-(3-nitrophenyl)-1,3,4-oxadiazol-2-yl)thio)methyl]-1,4-dihydro pyridine-3,5-dicarboxylate (9b) with (IC50 = 23±2.32 µM) was the most potent derivative against MCF-7 cells. Based on the results, the use of oxadiazole moiety in the C2 and C6 positions of 1,4-dihydropyridine ring system enhanced the cytotoxic potential of these derivatives. Therefore, some of the oxadiazole-substituted 1,4-DHPs may facilitate further modifications which result in the discovery of potent cytotoxic agents.
Downloads
Metrics
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution license 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
References
D. J. Triggle, Biochem. Pharmacol. 74 (2007) 1 (http://dx.doi.org/10.1016/j.bcp.2007.01.016)
C. Bladen, M. G. Gündüz, R. Şimşek, C. Şafak, G. W. Zamponi, Pflugers Arch – Eur. J. Physiol. 466 (2014) 1355 (http://dx.doi.org /10.1007/s00424-013-1376-z)
R. Bansal, G. Narang, C. Calle, R. Carron, K. Pemberton, A. L. Harvey, Drug Dev. Res. 74 (2013) 50 (http://dx.doi.org/10.1002/ddr.21056)
N. Razzaghi-Asl, R. Miri, O. Firuzi, Iran. J. Pharm. Sci. 15 (2016) 413 (http://dx.doi.org/10.22037/IJPR.2016.1870)
A. Ahamed, I. A. Arif, M. Mateen, R. S. Kumar, A. Idhayadhull, Saudi J. Biol. Sci. 25 (2018) 1227 (http://dx.doi.org/10.1016/j.sjbs.2018.03.001)
J. Marín-Prida, G. L. P. Andreu, C. P. Rossignoli, M. G. Durruthy, E. O. Rodríguez, Y. V. Reyes, R. F. Acosta, S. A. Uyemura, L. C. Alberici, Toxicol. In Vitro 42 (2017) 21 (http://dx.doi.org/10.1016/j.tiv.2017.03.011)
D. Viradiya, S. Mirza, F. Shaikh, R. Kakadiya, A. Rathod, N. Jain, R. Rawal, A. Shah, Anticancer Agents Med. Chem. 17 (2017) 1003 (http://dx.doi.org/10.2174/1871520616666161206143251)
F. Shekari, H. Sadeghpour, K. Javidnia, L. Saso, F. Nazari, O. Firuzi, R. Miri, Eur. J. Pharmacol. 746 (2015) 233 (http://dx.doi.org/10.1016/j.ejphar.2014.10.058)
S. Tasaka, H. Ohmori, N. Gomi, M. Iino, T. Machida, A. Kiue, S. Naito, M. Kuwano, Bioorganic Med. Chem. Lett. 11 (2001) 275 (http://dx.doi.org/10.1016/S0960-894X(00)00651-X)
H. Engi, H. Sakagami, M. Kawase, A. Parecha, D. Manvar, H. Kothari, P. Adlakha, A. Shah, N. Motohashi, I. Ocsovszki, J. Molnar, In Vivo 20 (2006) 637 (https://www.researchgate.net/publication/6705056)
M. F. Mohamed, A. F. Darweesh, A. H. M. Elwahy, I. A. Abdelhamid, RSC Adv. 6 (2016) 40900 (http://dx.doi.org/10.1039/c6ra04974e)
O. Firuzi, K. Javidnia, E. Mansourabadi, L. Saso, A.R. Mehdipour, R. Miri, Arch. Pharm. Sci. Res. 36 (2013) 1392 (http://dx.doi.org/10.1007/s12272-013-0149-8)
M. G. Pavani, M. Nunez, P. Brigidi, B. Vitali, R. Gambari, Bioorg. Med. Chem. 10 (2002) 449 (http://dx.doi.org/10.1016/S0968-0896(01)00294-2)
R. Miri, A. Mehdipour, Bioorg. Med. Chem. 16 (2008) 8329 (http://dx.doi.org/10.1016/j.bmc.2008.07.025)
A. Zarrin, A. R. Mehdipour, R. Miri, Chem. Biol. Drug. Des. 76 (2010) 369 (http://dx.doi.org/10.1111/j.1747-0285.2010.01025.x)
J. R. Warr, F. Brewer, M. Anderson, J. Fergusson, Cell Biol. Int. Rep. 10 (1986) 389 (http://dx.doi.org/10.1016/0309-1651(86)90011-1)
T. Tsuruo, H. Kawabata, N. Nagumo, H. lida, Y. Kitatani, S. Tsukagoshi, Y. Sakurai, Cancer Chemother. Pharmacol. 15 (1985) 16 (http://dx.doi.org/10.1007/BF00257287)
T. Godfraind, J. Cardiovasc. Pharmacol. Ther. 19 (2014) 501 (http://dx.doi.org/10.1177/1074248414530508)
B. Laupeze, L. Amiot, N. Bertho, J. M. Grosset, G. Lehne, R. Fauchet, O. Fardel, Hum. Immunol. 62 (2001) 1073 (http://dx.doi.org/10.1016/S0198-8859(01)00307-X)
R. Surendrakumar, A. Manilal, A. J. Abdul Nasser, B. Merdekios, X. Chen, A. Idhayadhulla, J. Pharmacol. Toxicol. 9 (2014) 119 (https://dx.doi.org/10.3923/jpt.2014.119.128 )
A. B. Archana, D. R. Dinesh, S. G. Paraag, Y. S. Prabhakar, Int. J. Pharm. Chem. 4 (2014) 62 (http://dx.doi.org/10.7439/ijpc.v4i2.75)
M. Ziaie, K. Akbari Dilmaghani, A. Tukmechi, Acta Chim. Slov. 64 (2017) 895 (http://dx.doi.org/10.17344/acsi.2017.3506)
R. M. Shaker, ARKIVOC IX (2006) 59 (https://dx.doi.org/10.3998/ark.5550190.0007.904)
A. A. Aly, A. A. Hassan, M. M. Makhlouf, S. Brase, Molecules 25 (2020) 3036 (http://dx.doi.org/10.3390/molecules25133036)
A. A. Othman, M. Kihel, S. Amara, Arab. J. Chem. 12 (2019) 1660 (http://dx.doi.org/10.1016/j.arabjc.2014.09.003)
K. M. Dawood, A. M. Farag, H. A. Abdel-Aziz, Heteroat. Chem. 16 (2005) 621 (http://dx.doi.org/10.1002/hc.20162)
J. Shneine, Y. H. Alaraji, IJSR 5 (2016) 1411 (https://www.ijsr.net/get_abstract.php?paper_id=NOV161902)
S. D. Bajaj, O. A. Mahodaya, P. V. Tekade, V. B. Patil, S. D. Kukade, Russ. J. Gen. Chem. 87 (2017) 546 (http://dx.doi.org/10.1134/S1070363217030264)
V. Palermo, A. G. Sathicq, T. Constantieux, J. Rodriguez, P. G. Vazquez, G. P. Romanelli, Catal. Lett. 146 (2016) 1634 (http://dx.doi.org/10.1007/s10562-016-1784-8)
D. Viradiya, S. Mirza, F. Shaikh, R. Kakadiya, A. Rathod, N. Jain, R. Rawal, A. Shah, Anti-Cancer Agents Med. Chem. 17 (2017) 1003 (http://dx.doi.org/10.2174/1871520616666161206143251)
N. Razzaghi-Asl, R. Miri, O. Firuzi, Iran. J. Pharm. Res. 15 (2016) 413 (http://dx.doi.org/10.22037/ijpr.2016.1870)
R. Surendra kumar, A. Idhayadhulla, A. Jamal Abdul Nasser, K. Murali, Indian J. Chem., B 50 (2011) 1140 (http://nopr.niscair.res.in/handle/123456789/12520)
R. Sarkhosh Inanlou, M. Molaparast, A. Mohammadzadeh, V. Shafiei Irannejad, Chem. Biol. Drug. Des. 95 (2019) 215 (http://dx.doi.org/10.1111/cbdd.13621)
K. H. Chikhalia, D. B. Vashi, M. J. Patel, J. Enzyme Inhib. Med. Chem. 24 (2009) 617 (http://dx.doi.org/10.1080/14756360802318936)
M. Petrova, R. Muhamadejev, B. Vigante, B. Cekavicus, A. Plotniece, G. Duburs, E. Liepinsh, Molecules 16 (2011) 8041 (http://dx.doi.org/10.3390/molecules16098041).